Article thumbnail
Location of Repository

Cognitive impairment and 7-year mortality in dialysis patients

By Konstadina Griva, Jan Stygall, Matthew Hankins, Andrew Davenport, Michael Harrison and Stanton P. Newman

Abstract

Background: although dementia has predicted mortality in large dialysis cohorts, little is known about the relationship between less pronounced cognitive deficits and mortality in patients with end-stage renal disease. This study assessed whether cognitiveimpairment without dementia was an independent predictor of 7-year survival in dialysispatients after controlling for other risk factors.<br/><br/>Study design: prospective single-cohort study.<br/><br/>Setting &amp; participants: 145 prevalent dialysispatients from 2 units in London, UK, were followed up for 64.3 ± 27.4 months and censored at the time of change to a different treatment.<br/><br/>Predictors: cognitiveimpairment, defined as performance 1 standard deviation less than normative values on 2 or more cognitive tests within a neurocognitive battery assessing attention/concentration, memory, and psychomotor function domains. Depression, quality-of-life, and clinical measures also were obtained.<br/><br/>Outcomes &amp; measurements: all-cause mortality was the primary outcome. Cox proportional hazard models were used to assess the contribution of demographics and clinical and psychological measures and cognitiveimpairment to mortality.<br/><br/>Results: 98 (67.6%) patients were cognitively impaired at baseline. At follow-up, 56 (38.6%) patients had died, 29 of cardiac causes. Unadjusted Kaplan-Meier analysis showed higher mortality in cognitively impaired patients, in whom 7-year survival was 49% versus 83.2% in those with no cognitiveimpairment (P &lt; 0.001). Mortality risk associated with cognitiveimpairment remained significant in adjusted analysis controlling for sociodemographic, clinical, and psychological factors (adjusted HR, 2.53; 95% CI, 1.03-6.22; P = 0.04).<br/><br/>Limitations: small sample size and number of events.<br/><br/>Conclusions: cognitiveimpairment is an independent predictor of mortality in dialysispatients. Although the implications of early recognition and treatment of cognitiveimpairment for clinical outcomes are unclear, these results suggest that patient management protocols should attempt to ensure prevention of cognitive decline in addition to managing coexisting medical condition

Topics: RB, RC0321
Year: 2010
OAI identifier: oai:eprints.soton.ac.uk:187289
Provided by: e-Prints Soton
Sorry, our data provider has not provided any external links therefore we are unable to provide a link to the full text.

Suggested articles


To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.